These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 17067913)

  • 1. Adverse events following immunisation: desperately seeking surveillance.
    Buttery J; La Vincente S; Andrews R; Kempe A; Royle J
    Lancet Infect Dis; 2006 Nov; 6(11):680-1. PubMed ID: 17067913
    [No Abstract]   [Full Text] [Related]  

  • 2. Annual report: surveillance of adverse events following immunisation in Australia, 2008.
    Menzies R; Mahajan D; Gold MS; Roomiani I; McIntyre P; Lawrence G
    Commun Dis Intell Q Rep; 2009 Dec; 33(4):365-81. PubMed ID: 20301966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supplementary report: surveillance of adverse events following immunisation among children aged < 7 years in Australia, 1 January to 30 June 2008.
    Lawrence GL; Mahajan D; Roomiani I
    Commun Dis Intell Q Rep; 2009 Mar; 33(1):27-31. PubMed ID: 19618765
    [No Abstract]   [Full Text] [Related]  

  • 4. Surveillance of adverse events following immunisation: Australia, 2000-2002.
    Lawrence G; Menzies R; Burgess M; McIntyre P; Wood N; Boyd I; Purcell P; Isaacs D
    Commun Dis Intell Q Rep; 2003; 27(3):307-23. PubMed ID: 14510057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reporting of adverse events following immunization in Australia.
    Isaacs D; Lawrence G; Boyd I; Ronaldson K; McEwen J
    J Paediatr Child Health; 2005 Apr; 41(4):163-6. PubMed ID: 15813867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supplementary report: Surveillance of adverse events following immunisation among children aged less than seven years in Australia, 1 January to 30 June 2011.
    Mahajan D; Cook J; McIntyre P; Macartney K; Menzies R
    Commun Dis Intell Q Rep; 2012 Mar; 36(1):114-9. PubMed ID: 23153088
    [No Abstract]   [Full Text] [Related]  

  • 7. Adverse events temporally associated with immunizing agents--1988 report.
    Duclos P; McCarthy R; Koch J; Carter A
    Can Dis Wkly Rep; 1990 Aug; 16(32):157-64. PubMed ID: 2208346
    [No Abstract]   [Full Text] [Related]  

  • 8. Supplementary report: surveillance of adverse events following immunisation among children aged less than seven years in Australia, 1 January to 30 June 2012.
    Mahajan D; Cook J; Dey A; Macartney K; Menzies R
    Commun Dis Intell Q Rep; 2013 Jun; 37(2):E130-4. PubMed ID: 24168086
    [No Abstract]   [Full Text] [Related]  

  • 9. Blood lead in Canadian children: a current perspective.
    Godolphin W; Schmitt N; Anderson TW
    CMAJ; 1993 Feb; 148(4):517-9. PubMed ID: 8381702
    [No Abstract]   [Full Text] [Related]  

  • 10. Annual report: Surveillance of adverse events following immunisation in Australia, 2011.
    Mahajan D; Cook J; Dey A; Macartney K; Menzies RI
    Commun Dis Intell Q Rep; 2012 Dec; 36(4):E315-32. PubMed ID: 23330706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunisation coverage: Australia 2001.
    N S W Public Health Bull; 2003; 14(4-5):94. PubMed ID: 12806410
    [No Abstract]   [Full Text] [Related]  

  • 12. Towards a gold standard for national prevalence estimates of birth defects.
    Meyer RE; Sever LE
    Birth Defects Res A Clin Mol Teratol; 2006 Nov; 76(11):770-1. PubMed ID: 17094132
    [No Abstract]   [Full Text] [Related]  

  • 13. NSW Annual Adverse Events Following Immunisation Report, 2009.
    Mahajan D; Campbell-Lloyd S; Roomiani I; Menzies RI
    N S W Public Health Bull; 2010; 21(9-10):224-33. PubMed ID: 21211475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supplementary report: surveillance of adverse events following immunisation among children aged less than seven years in Australia, 1 January to 30 June 2009.
    Mahajan D; Menzies R; Roomiani I; Lawrence G
    Commun Dis Intell Q Rep; 2010 Mar; 34(1):49-53. PubMed ID: 20521499
    [No Abstract]   [Full Text] [Related]  

  • 15. Supplementary report: surveillance of adverse events following immunisation among children aged less than 7 years in Australia, 1 January to 30 June 2005.
    Lawrence G; Boyd I
    Commun Dis Intell Q Rep; 2005; 29(4):413-6. PubMed ID: 16465935
    [No Abstract]   [Full Text] [Related]  

  • 16. Supplementary report: surveillance of adverse events following immunisation among children aged less than 7 years in Australia, 1 January to 30 June 2007.
    Lawrence GL; Aratchige PE; Hill R
    Commun Dis Intell Q Rep; 2007 Dec; 31(4):379-82. PubMed ID: 18268878
    [No Abstract]   [Full Text] [Related]  

  • 17. Supplementary report: surveillance of adverse events following immunisation among children aged < 7 years in Australia, 1 January to 30 June 2006.
    Lawrence G; Boyd I
    Commun Dis Intell Q Rep; 2006; 30(4):438-42. PubMed ID: 17330385
    [No Abstract]   [Full Text] [Related]  

  • 18. Supplementary report: surveillance of adverse events following immunisation among children aged less than 7 years in Australia, 1 January to 30 June 2010.
    Mahajan D; Menzies R; Cook J; Macartney K; Mclntyre P
    Commun Dis Intell Q Rep; 2011 Mar; 35(1):21-8. PubMed ID: 21698980
    [No Abstract]   [Full Text] [Related]  

  • 19. Methodology for measuring Australia's childhood immunisation coverage.
    O'Brien ED; Sam GA; Mead C
    Commun Dis Intell; 1998 Mar; 22(3):36-7. PubMed ID: 9557387
    [No Abstract]   [Full Text] [Related]  

  • 20. Annual report: surveillance of adverse events following immunisation in Australia, 2010.
    Mahajan D; Cook J; McIntyre PB; Macartney K; Menzies RI
    Commun Dis Intell Q Rep; 2011 Dec; 35(4):263-80. PubMed ID: 22624487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.